Results 51 to 60 of about 14,731 (198)

3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates.

Physica medica (Testo stampato), 2020
BACKGROUND To improve therapy outcome of Yttrium-90 selective internal radiation therapy (90Y SIRT), patient-specific post-therapeutic dosimetry is required.
J. Brosch, A. Gosewisch, L. Kaiser, M. Seidensticker, J. Ricke, Johannes Zellmer, P. Bartenstein, S. Ziegler, H. Ilhan, A. Todica, G. Böning   +10 more
semanticscholar   +1 more source

The Preparation and Performance of the Temperature-Sensitive Yttrium-90 Radioactive Gel

Journal of Isotopes
Radionuclides combined with the temperature-sensitive gel carrier could apply to tumor therapy. In this paper，the preparation of yttrium-90 radioactive gel was conducted while performance of gel property was introduced.
Jiaju MA, Bo LI, Ning LUO, Yingjiang HU, Yunming CHEN, Jingsong ZHANG   +5 more
doaj   +1 more source

Determination of Radiation Absorbed Dose to Primary Liver Tumors and Normal Liver Tissue Using Post Radioembolization 90Y PET

Frontiers in Oncology, 2014
Background: Radioembolization with Yttrium-90 (90Y) microspheres is becoming a more widely used transcatheter treatment for unresectable hepatocellular carcinoma (HCC).
Shyam Mohan Srinivas, Navin eNatarajan, Joshua eKuroiwa, Bana eBazerbashi, Frank P DiFilippo, Naichang eYu, Shetal N Shah, Gordon eMcLennan, Nancy eObuchowski   +8 more
doaj   +1 more source

Design and optimization of processes for recovering rare earth elements from end‐of‐life permanent magnets

AIChE Journal, EarlyView.
Abstract Recovery of rare earth elements (REEs) from end‐of‐life (EOL) products represents a strategic opportunity to strengthen the domestic supply chain for rare earth elements. This work presents a superstructure‐based optimization framework for finding the most economical processing pathway for different EOL rare earth permanent magnets (REPMs ...
Chris Laliwala, Oluwamayowa O. Amusat, Akintomiwa Ojo, Alejandro Garciadiego, Thomas Tarka, Debangsu Bhattacharyya, Ana I. Torres   +6 more
wiley   +1 more source

Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma

Gut, 2018
Objectives Yttrium-90 (Y90)-radioembolisation (RE) significantly regresses locally advanced hepatocellular carcinoma and delays disease progression. The current study is designed to deeply interrogate the immunological impact of Y90-RE, which elicits a ...
Valerie Chew, Y. Lee, Lu Pan, N. J. M. Nasir, C. Lim, C. Chua, L. Lai, S. Hazirah, T. Lim, B. Goh, A. Chung, R. Lo, D. Ng, R. F. Filarca, S. Albani, P. Chow   +15 more
semanticscholar   +1 more source

Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review

World Journal of Gastrointestinal Oncology, 2020
BACKGROUND Liver metastases secondary to breast cancer are associated with unfavourable prognosis. Radioembolization with ytrrium-90 is an emerging option for management of liver metastases of breast cancer when other systemic therapies have failed to ...
M. Feretis, A. Solodkyy
semanticscholar   +1 more source

Yttrium-90 radioembolization as a possible new treatment for brain cancer: proof of concept and safety analysis in a canine model

EJNMMI Research, 2020
Purpose To evaluate the safety, feasibility, and preliminary efficacy of yttrium-90 ( 90 Y) radioembolization (RE) as a minimally invasive treatment in a canine model with presumed spontaneous brain cancers.
A. Pasciak, S. Manupipatpong, F. Hui, L. Gainsburg, R. Krimins, M. Zink, C. Brayton, Meaghan Morris, Jaime Sage, D. Donahue, M. Dreher, D. Kraitchman, C. Weiss   +12 more
semanticscholar   +1 more source

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

Journal of Hepatocellular Carcinoma, 2016
Armeen Mahvash,1 Ravi Murthy,1 Bruno C Odisio,1 Kanwal Pratap Raghav,2 Lauren Girard,2 Sheree Cheung,1 Van Nguyen,3 Joe Ensor,4 Sameer Gadani,5 Khaled M Elsayes,6 Reham Abdel-Wahab,1,7 Manal Hassan,1 Ahmed S Shalaby,1 James C Yao,1 Michael J Wallace,1 ...
Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO   +15 more
doaj  

Radioembolization Treatment for Liver Cancer

Bezmiâlem Science, 2016
Although curative treatment is surgery (resection/transplantation) and for small lesions ablative strategies, in primary liver carcinomas such as hepatocellular carcinoma and cholangiocellular carcinoma, palliative treatment is used for most of these ...
Ezgi Başak ERDOĞAN, Hüseyin ÖZDEMİR, Mehmet AYDIN   +2 more
doaj   +1 more source

Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion

Case Reports in Oncology, 2020
Use of yttrium-90 (Y-90) is used for primary liver tumors and a handful of liver metastatic lesions. Y-90 treatment for metastatic adrenocortical carcinoma (ACC) to the liver is currently off-label, with one previously documented case report.
Nicholas Pigg, Daniel Aboubechara, Roberto Fourzali, Brian Baigorri   +3 more
doaj   +1 more source